U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Links shared publicly online about this topic.
- 1,672total visits
U.S. Food and Drug Administration Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Crestor (rosuvastatin calcium) is used to treat pediatric patients with heterozygous familial hypercholesterolemia. Includes Crestor side effects, interactions and indications.
View full resource at drugs.com
Tags: Cholesterol Medication, Mineral, Calcium, Drug, Children's Health, FDA, Crestor
Most Recently Shared on October 16, 2009 at 10:03 pm By:
FDA Approves Crestor for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia - http://bit.ly/DrHi0
Advertisement
